Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05609578 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 84 sites in the US |
| Sponsor | Mirati Therapeutics Inc. |
| Last Updated on CT.gov | August 17, 2025 (Aug 17, 2025) |
As of March 2, 2026: Clinical trial NCT05609578 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 84 locations across the United States. The study is sponsored by Mirati Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05609578 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 84 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05609578 was last updated Aug 17, 2025 (August 17, 2025). HelloStudys verifies this status automatically.